Vera Therapeutics, Inc.

Ownership Transactions Reported by 26 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+250K	70.1%	$21.11	+$5.28M
Sells	2	-107K	29.9%	$39.58	-$4.22M
Net	-1	+143K	40.2%		+$1.06M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Patrick G. Enright	Director	$80.4M	+$5.28M	+7.03%	Jun 23, 2025
Commodore Capital Lp	10%+ Owner	$79.2M			Jan 10, 2024
Sofinnova Venture Partners X, L.P.	10%+ Owner	$62.4M			Feb 6, 2023
Kurt Von Emster	Director	$53.6M			May 17, 2021
Carlyle Group Inc.	10%+ Owner	$53.3M			Aug 17, 2022
Abingworth LLP	10%+ Owner	$53.3M			May 13, 2021
Longitude Prime Partners, LLC	10%+ Owner	$30.9M			Feb 6, 2023
Longitude Capital Partners IV, LLC	10%+ Owner	$30.9M			Feb 6, 2023
Marshall Fordyce	PRESIDENT AND CEO, Director	$12.1M	-$3.78M	-23.8%	Feb 21, 2025
Beth C. Seidenberg	Director	$6.72M			May 14, 2025
Sean Grant	Chief Financial Officer	$4.13M			Feb 18, 2025
Jason S. Carter	Chief Legal Officer	$2.6M			Nov 18, 2024
Robert Brenner	Chief Medical Officer	$1.15M			Feb 18, 2025
David Lee Johnson	Chief Operating Officer	$1.13M			Feb 18, 2025
William D. Turner	Chief Development Officer	$945K			Feb 18, 2025
Joanne Curley	Chief Development Officer	$485K			Aug 21, 2023
Joseph R. Young	Svp, Finance, Chief Acct Offcr	$228K	-$436K	-65.7%	Nov 11, 2025
Celia Lin	Chief Medical Officer	$198K			Aug 21, 2023
Christy J. Oliger	Director	$129K			May 14, 2025
Scott W. Morrison	Director				May 14, 2025
Andrew Cheng	Director				May 14, 2025
Jonathan Wolter	Chief Financial Officer				May 13, 2021
Ares Trading S.A.	10%+ Owner				May 13, 2021
Maha Katabi	Director				May 14, 2025
Kimball Hall	Director				May 14, 2025
Michael Morrissey	Director				May 14, 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.